Dosage protocol · Brain Health & Nootropics
Selank 10 mg
10 mL final volume: 1 mg/mL, 100 mcg per verified 0.10 mL spray, and 100 nominal sprays.
- 5 mL final volume: 2 mg/mL, 200 mcg per verified 0.10 mL spray, and 50 nominal sprays.
- 10 mL final volume: 1 mg/mL, 100 mcg per verified 0.10 mL spray, and 100 nominal sprays.
- Label and research log: Record the peptide amount, final volume, concentration, pump output, preparation date, priming sprays, and actuation count.
- Storage materials: Light-protective, temperature-controlled storage appropriate to the validated formulation.
Reconstitution
Selank dosage chart
| Draw | Vehicle Added After Transfer | Final Concentration | Draw |
|---|---|---|---|
| 5.0 mL | About 2.0 mL | 2,000 mcg/mL | 200 mcg 50 nominal sprays |
| 10.0 mL | About 7.0 mL | 1,000 mcg/mL | 100 mcg 100 nominal sprays |
| Dose | Draw | Draw |
|---|---|---|
| 300 mcg | 1.5 theoretical sprays | 3 sprays |
| 900 mcg | 4.5 theoretical sprays | 9 sprays |
| 2,700 mcg | 13.5 theoretical sprays | 27 sprays |
| Source | Research Context | Dose |
|---|---|---|
| Zozulia et al., 2008 [1] | 62 adults with generalized anxiety disorder or neurasthenia | Selank 0.15% nasal drops at 2.7 mg per day, reported as 36 drops divided across three administrations, with outcomes followed through day 14. |
| Syunyakov et al., 2012 [2] | 20 adults with generalized anxiety disorder | 2,700 mcg per day intranasally. The pharmaco-EEG analysis also examined a single 900 mcg exposure. |
| Panikratova et al., 2020 [4] | Healthy-volunteer functional connectivity study | One intranasal exposure using 0.15% Selank solution, 60 microliters per nostril, described as a 0.2 mg total amount. |
| Verified Actuator Output | Draw | Draw |
|---|---|---|
| 0.05 mL | 100 mcg | 50 mcg |
| 0.10 mL | 200 mcg | 100 mcg |
| 0.13 mL | 260 mcg | 130 mcg |
How much to draw
The Draw column shows exactly where to stop on a U-100 insulin syringe. Different vial size or dose? The calculator below recomputes it live.
Supplies needed
Supplies needed
Peptide vial
The lyophilized compound
Bacteriostatic water
For reconstitution
U-100 insulin syringes
One per injection
Alcohol swabs
Stopper + site each time
How it works
Selank is a synthetic heptapeptide — a chain of seven amino acids — built from the sequence of tuftsin, a naturally occurring immune-signaling tetrapeptide, with an added Pro-Gly-Pro extension.[1] It was developed in Russia and is studied mainly as a nootropic and anxiolytic compound, proposed to reduce anxiety and support cognitive function, though the evidence behind those labels is uneven.
Selank has a prescription history in Russia, where it has been studied and used clinically for anxiety-related conditions, but it has no equivalent regulatory standing in the United States.[2] That regional gap is one of the most important things to understand about how Selank is discussed online versus how it is actually regulated.
Benefits & side effects
Human evidence for Selank is small, early, and concentrated in Russian clinical literature. A 2008 study compared Selank against the benzodiazepine medazepam in 62 patients with generalized anxiety disorder and neurasthenia, reporting broadly similar anxiolytic effects between the two.[4] A 2014 study compared Selank with another benzodiazepine, phenazepam, in 60 patients with phobic-anxiety and somatoform disorders, again reporting anxiolytic benefit alongside mild nootropic effects.[5]
These studies are clinically interesting but limited by small sample sizes, regional publication context, and comparator drugs not standard in U.S. practice. Cognitive, neuroprotective, and stress-resilience claims rest on an even thinner base — mostly rodent studies of memory and chronic-stress models — and should be read as preliminary rather than established.[6]
Calculator
Plan your own dose
Reconstituting a different vial size or targeting a different dose? Run the numbers.
Reconstitution
Your dose
Other vial sizes
